NCT06857318View on ClinicalTrials.gov

Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

August 31, 2023

Study Completion Date

January 1, 2024

Conditions
COVID 19
Interventions
BIOLOGICAL

Colostrum Nasal Spray

24 hours use of nasal spray of colostrum from MERS-CoV positive camels- 6 doses total

OTHER

Water for injection

24 hours use of a nasal spray of water for injection- 6 doses total

Trial Locations (1)

91120

Hadassah Hebrew University, Jerusalem

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT06857318 - Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial. | Biotech Hunter | Biotech Hunter